John H Krege

John H Krege

UNVERIFIED PROFILE

Are you John H Krege?   Register this Author

Register author
John H Krege

John H Krege

Publications by authors named "John H Krege"

Are you John H Krege?   Register this Author

53Publications

757Reads

42Profile Views

Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.

Headache 2020 Mar 13;60(3):576-588. Epub 2020 Jan 13.

Headache & Craniofacial Pain Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/head.13731DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064990PMC
March 2020

Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine.

Cephalalgia 2019 Oct 3;39(12):1569-1576. Epub 2019 Jul 3.

Division of Headache Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0333102419859313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791026PMC
October 2019

Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis.

Bone 2019 03 27;120:1-8. Epub 2018 Sep 27.

Department of Preventive Medicine and Public Health, University of Jaén, Spain; CIBERESP, Institute Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S87563282183036
Publisher Site
http://dx.doi.org/10.1016/j.bone.2018.09.020DOI Listing
March 2019

Teriparatide in patients with osteoporosis and type 2 diabetes.

Bone 2016 10 1;91:152-8. Epub 2016 Jul 1.

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2016.06.017DOI Listing
October 2016

Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.

J Clin Endocrinol Metab 2016 Apr 9;101(4):1353-63. Epub 2016 Feb 9.

Regional Bone Center (D.W.D., H.Z., R.L.), Helen Hayes Hospital, West Haverstraw, New York; Department of Pathology and Cell Biology (D.W.D.), College of Physicians and Surgeons of Columbia University, New York; Department of Medicine (R.R.R.), Division of Endocrinology, School of Medicine, Creighton University, Omaha, Nebraska; Rheumatology and Bone Diseases Research Group (J.P.B.), CHU de Quebec (CHUL) Research Centre and Department of Medicine, Laval University, Quebec City, Quebec, Canada; United Osteoporosis Centers (C.P.R.), Gainesville, Georgia; New Mexico Clinical Research & Osteoporosis Center (E.M.L.), Albuquerque, New Mexico; Department of Medicine (P.D.M.), Colorado Center for Bone Research, Lakewood, Colorado; Bone & Mineral Research Laboratory (S.D.R.), Henry Ford Hospital, Detroit, Michigan; Department of Medicine (Endocrinology) (D.L.K.), University of British Columbia, Vancouver, British Columbia, Canada; Department of Medicine (R.L.), College of Physicians and Surgeons of Columbia University, New York; Lilly Research Laboratories (J.H.K., J.A.), Eli Lilly and Company, Indianapolis, Indiana; Musculoskeletal and Men's Health (K.A.T., V.A.R.), Lilly USA, LLC, Indianapolis, Indiana; Research and Development - Bio-Medicines (B.J.), Eli Lilly Canada Inc., Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-4181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880160PMC
April 2016

Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis.

J Clin Densitom 2015 Oct-Dec;18(4):506-11. Epub 2015 Mar 29.

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocd.2015.02.004DOI Listing
January 2016

Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.

Bone 2014 Oct 15;67:246-56. Epub 2014 Jul 15.

Lilly USA, LLC, Lilly Technology Center South, Drop Code 5028 Indianapolis, IN 46221, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S87563282140026
Publisher Site
http://dx.doi.org/10.1016/j.bone.2014.07.014DOI Listing
October 2014

Changes in vitamin D metabolites during teriparatide treatment.

Bone 2012 Jun 9;50(6):1368-71. Epub 2012 Mar 9.

Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2012.02.635DOI Listing
June 2012

Long-term raloxifene for postmenopausal osteoporosis.

Curr Med Res Opin 2011 Sep 25;27(9):1755-61. Epub 2011 Jul 25.

Osteoporosis Research Center, Creighton University, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007995.2011.606312DOI Listing
September 2011

PINP as an aid for monitoring patients treated with teriparatide.

Bone 2011 Apr 17;48(4):798-803. Epub 2010 Dec 17.

Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Sannomiya Plaza Building, 7-1-5 Isogamidori, Kobe 651-0086, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2010.12.006DOI Listing
April 2011

First fractures among postmenopausal women with osteoporosis.

J Bone Miner Metab 2010 Jul 7;28(4):485-8. Epub 2010 Jan 7.

Lilly USA, LLC, Lilly Corporate Center, Drop Code 4109, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00774-009-0144-9DOI Listing
July 2010

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Bone 2010 Apr 6;46(4):929-34. Epub 2010 Jan 6.

University of Sheffield Bone Metabolism Group, Metabolic Bone Centre, Sorby Wing, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S875632820902123
Publisher Site
http://dx.doi.org/10.1016/j.bone.2009.12.021DOI Listing
April 2010

Benefits and risks of raloxifene by vertebral fracture status.

Curr Med Res Opin 2010 Jan;26(1):71-6

Lilly USA, LLC, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007990903427082DOI Listing
January 2010

Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment.

Curr Med Res Opin 2009 Apr;25(4):921-8

Department of Epidemiology and Biostatistics, University of California-San Francisco, 185 Berry St., San Francisco, CA 94107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/03007990902790993DOI Listing
April 2009

Response to teriparatide in patients with baseline 25-hydroxyvitamin D insufficiency or sufficiency.

J Clin Endocrinol Metab 2007 Dec 2;92(12):4630-6. Epub 2007 Oct 2.

Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, Massachusetts 02111-1524, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2007-0239DOI Listing
December 2007

Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.

J Clin Endocrinol Metab 2007 Sep 3;92(9):3535-41. Epub 2007 Jul 3.

FACP, Colorado Center for Bone Research, 3190 South Wadsworth, Suite 250, Lakewood, Colorado 80227, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2006-2439DOI Listing
September 2007

Osteosarcoma and teriparatide?

J Bone Miner Res 2007 Feb;22(2):334

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1359/jbmr.061111
Publisher Site
http://dx.doi.org/10.1359/jbmr.061111DOI Listing
February 2007

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.

J Bone Miner Res 2006 Nov;21(11):1785-90

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.060802DOI Listing
November 2006

New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status.

J Clin Densitom 2006 Apr-Jun;9(2):144-9. Epub 2006 May 2.

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocd.2006.02.001DOI Listing
September 2006

Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.

J Am Geriatr Soc 2006 May;54(5):782-9

Leuven University Center for Metabolic Bone Diseases and Division of Geriatric Medicine, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1532-5415.2006.00695.xDOI Listing
May 2006

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Osteoporos Int 2006 Feb 2;17(2):273-80. Epub 2005 Sep 2.

University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00198-005-2013-2DOI Listing
February 2006

Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.

Curr Med Res Opin 2006 Jan;22(1):61-6

University of Sheffield, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079905X75096DOI Listing
January 2006

Prognostic utility of a semiquantitative spinal deformity index.

Bone 2005 Aug;37(2):175-9

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2005.04.003DOI Listing
August 2005

Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.

J Rheumatol 2005 Aug;32(8):1556-62

Colorado Center for Bone Research, Lakewood, 80227, USA.

View Article

Download full-text PDF

Source
August 2005

Teriparatide, osteoporosis, calcium, and vitamin D.

N Engl J Med 2005 Aug;353(6):634-5; author reply 634-5

View Article

Download full-text PDF

Source
August 2005

The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis.

Curr Med Res Opin 2005 Jul;21(7):1027-34

UCSF-OARG and Synarc Inc., San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1185/030079905X49671DOI Listing
July 2005

Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures.

J Clin Endocrinol Metab 2005 Mar 21;90(3):1583-7. Epub 2004 Dec 21.

Lilly Research Laboratories, DC 6121, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-0826DOI Listing
March 2005